Ibandronate sodium - CAS 138926-19-9
Catalog number: 138926-19-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C9H23NO7P2.Na.H2O
Molecular Weight:
360.23
COA:
Inquire
Targets:
Others
Description:
Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
BM-21.0955
MSDS:
Inquire
1.Effect of ibandronate on bending strength and toughness of rodent cortical bone: Possible implications for fracture prevention.
Savaridas T1, Wallace RJ2, Dawson S2, Simpson AH3. Bone Joint Res. 2015 Jun;4(6):99-104. doi: 10.1302/2046-3758.46.2000311.
OBJECTIVES: There remains conflicting evidence regarding cortical bone strength following bisphosphonate therapy. As part of a study to assess the effects of bisphosphonate treatment on the healing of rat tibial fractures, the mechanical properties and radiological density of the uninjured contralateral tibia was assessed.
2.Effect of ibandronate on bending strength and toughness of rodent cortical bone: Possible implications for fracture prevention.
Savaridas T1, Wallace RJ2, Dawson S2, Simpson AH3. Bone Joint Res. 2015 Jun;4(6):99-104. doi: 10.1302/2046-3758.46.2000311.
OBJECTIVES: There remains conflicting evidence regarding cortical bone strength following bisphosphonate therapy. As part of a study to assess the effects of bisphosphonate treatment on the healing of rat tibial fractures, the mechanical properties and radiological density of the uninjured contralateral tibia was assessed.
3.Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients.
Sánchez-Escuredo A1, Fuster D, Rubello D, Muxí A, Ramos A, Campos F, Marzola MC, Cook GJ, Tapias A, Torregrosa JV. Nucl Med Commun. 2015 Aug;36(8):815-8. doi: 10.1097/MNM.0000000000000316.
INTRODUCTION: Bisphosphonates may aid in treating and preventing bone loss promoted by chronic immunosuppressive treatment and secondary hyperparathyroidism in renal transplant (RT) patients. However, the effectiveness of bisphosphonates is compromised by poor patient compliance. The objective of the study was to compare the effects of once monthly ibandronate with those of weekly risedronate administration on bone mineral density (BMD) and renal function in RT patients.
4.Impurity profiling of ibandronate sodium by HPLC-CAD.
Wahl O1, Holzgrabe U2. J Pharm Biomed Anal. 2015 Oct 10;114:254-64. doi: 10.1016/j.jpba.2015.06.002. Epub 2015 Jun 6.
The modern bisphosphonate drug ibandronate sodium, a challenging candidate for impurity profiling, was analyzed using high performance liquid chromatography (HPLC) combined with corona charged aerosol detection (CAD). Separation was achieved on a mixed mode column combining hydrophobic C18 and strong anion exchange retention mechanisms using a mass spectrometer compatible volatile mobile phase consisting of trifluoroacetic acid and acetonitrile while gradient elution was applied. The method was validated following the ICH guideline Q2(R1) and found suitable for the assessment of ibandronate's related substances. The observed CAD-response for all identified impurities was linear (R(2)>0.995) over a small concentration range (0.05-0.25) and a quantification limit of at least 0.03% was found. Four batches of two different manufacturers were tested by means of the method. None of the batches contained a single impurity above 0.05%. The major impurities of all batches were the synthesis by-products N-desmethyl- and N-despentyl ibandronate as well as N,N-dimethyl pamidronate.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


LY 140091
(CAS: 74814-56-5)

LY 140091 is a bio-active chemical, but no detailed information has been published yet.

FY26 (complex)
(CAS: 1255143-82-8)

This active moleculr is a Os(II) anticancer drug candidate. It can generate reactive oxygen species and disrupt the redox balance in cancer cells. Using FY26 an...

CAS 481-72-1 Aloe-emodin

Aloe-emodin
(CAS: 481-72-1)

Aloe-emodin is an interferon-inducing agent with IC50 of about 1 μg/mL for JEV and of about 0.33 μg/mL for EV71.

CAS 1093069-32-9 JNJ-39327041

JNJ-39327041
(CAS: 1093069-32-9)

JNJ-39327041 is a bio-active chemical compound.

CAS 18771-50-1 Tetrahydrouridine

Tetrahydrouridine
(CAS: 18771-50-1)

Tetrahydrouridine, a derivative of Uridine, is a potent and reversible competitive inhibitor of cytidine deaminase (CDD) (Ki values = 54 and 240 nM for human an...

CAS 370893-06-4 Ancriviroc

Ancriviroc
(CAS: 370893-06-4)

Ancriviroc, an oximino-piperidino-piperidine-amide, is a CCR5 receptor antagonist.

STK321130
(CAS: 923562-23-6)

STK321130 is potent FLT3 inhibitor with IC50 value of less than 1 μM.

CAS 110267-81-7 Amrubicin

Amrubicin
(CAS: 110267-81-7)

Amrubicin is a novel anthracycline derivative for treatment of bladder carcinoma.

AMZ30
(CAS: 1313613-09-0)

AMZ30, a PME-1 inhibitor, could inhibit PME-1 irreversiblely and be significant in the pharmacological study of determinating the demethylated PP2A function. IC...

CAS 38642-49-8 Benzoylpaeoniflorin

Benzoylpaeoniflorin
(CAS: 38642-49-8)

Benzoylpaeoniflorin was found to be active against cyclooxygenase-1 and cyclooxygenase-2 enzymes.

BPD-Ring B
(CAS: 143986-17-8)

BPD-Ring B is a product from the synthesis of verteporfinin. It can be used for making porphyrin-related dye, nanoparticles, photosensitizers, and other photody...

CAS 1665-48-1 Metaxalone

Metaxalone
(CAS: 1665-48-1)

Metaxalone is a muscle relaxant. The mechanism of action of metaxalone in humans is not fully understood. It was suggested that it acts through general central ...

TAK-603
(CAS: 158146-85-1)

TAK-603, a quinoline derivative, has been found to be an immunomodulator that was once studied in sorts of inflammatory diseases.

CAS 122018-58-0 PLP(139-151)

PLP(139-151)
(CAS: 122018-58-0)

PLP(139-151), a synthetic myelin proteolipid protein (PLP) fragment, induces experimental autoimmune encephalomyelitis (EAE).

CAS 55297-96-6 Tiamulin Fumarate

Tiamulin Fumarate
(CAS: 55297-96-6)

Tiamulin Fumarate is a derivative of Pleuromutilin, acts as an antibacterial.

CAS 586357-02-0 O-Desmethyl Mebeverine Acid

O-Desmethyl Mebeverine Acid
(CAS: 586357-02-0)

O-Desmethyl Mebeverine Acid is a metabolite of Mebeverine, which is an antispasmodic.

CAS 83480-29-9 Voglibose

Voglibose
(CAS: 83480-29-9)

Voglibose is an N-substituted derivative of valiolamine, excellent inhibitory activity against α-glucosidases and its action against hyperglycemia and various d...

CAS 145375-43-5 Mitiglinide

Mitiglinide
(CAS: 145375-43-5)

Mitiglinide is a succinic acid derivative with hypoglycemic activity. It belongs to the meglitinide class of blood glucose-lowering drugs. It is a drug for the ...

CAS 126643-37-6 KT 5823

KT 5823
(CAS: 126643-37-6)

KT 5823 is a cell-permeable, selective inhibitor of cGMP-dependent protein kinase (PKG) (Ki values are 0.23, 4 and > 10 μM for inhibition of PKG, PKC and PKA re...

CAS 1046045-61-7 FGH10019

FGH10019
(CAS: 1046045-61-7)

FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 μM, 5-10 times lower than the IC50 of fatostatin (~10 μM).

Chemical Structure

CAS 138926-19-9 Ibandronate sodium

Quick Inquiry

Verification code

Featured Items